News

ADDS becomes APROVA

  On July 2013, ALTEN (www.alten.com) acquired the European Contract Research Organization Advanced Drug & Device Services (ADDS) and regroups its Life Sciences solutions in a new structure, APROVA (www.aprova-cro.com), headquartered in Brussels. With annual revenues of 1 198 M€ in 201... Read more


ADDS changed its name

ADDS changed its name : Advanced Drug and Device Services Since 1st January 2012, ADDS changed its name in order to be in line with its new international strategy to be a leading Contract Research and Safety Organisation (CRO&CSO). For more information, please contact Aurore Andre aa... Read more


ADDS is investing by taking a 25% stake in the European Service Provider: JSW-Clinical Investigation Ltd

ADDS is investing by taking a 25% stake in the Pan-European Services Provider : JSW-Clinical Investigation Ltd   In order to leverage the possibilities to provide clients the best international strategy with the optimal local approaches and sophisticated services in preclinical, clinical, data... Read more


10th Annual BIOMED Meeting, Tel Aviv, Israël

10th Annual BIOMED Meeting, Tel Aviv, Israël   ADDS is delighted to invite you to a conference followed by a sushi cocktail:   “Adapt your strategy to the changing European Medical   Device Landscape:   A Convergence approach on how to access the market”     Tuesday, May 24... Read more


8th Annual Meeting of CROs and Pharmaceutical companies, Clinical Trials 2010 - Sept. 29-30

Dr. Michel LEVY, CEO of ADDS, will be lecturing on "PATIENTS RECRUITMENT: new approaches to optimize the cost-quality ratio" at the event ‘8čme Réunion Annuelle Laboratoires et CROs, Essais Cliniques 2010’ taking place in Paris on Sept. 29-30, 2010. About the 8th Annual Meeting of CROs and Phar... Read more


4th Annual Pacific Drug Safety Summit (PDSS) in San Francisco - Sept. 23-24, 2010

As a sponsor of the PDSS Event, Advanced Drug Development Services (ADDS) is pleased to invite you to meet us there. Dr. Irčne Fermont, EU QPPV, ADDS VP Risk Management & Pharmacovigilance, will be giving a lecture on "Good Pharmacovigilance Practices and Risk Management Plans in Europe" (Sept. ... Read more


46th DIA Annual Meeting in Washington, DC - June 13-17, 2010

Advanced Drug Development Services (ADDS) is pleased to announce that Dr. Irčne FERMONT, VP Pharmacovigilance & Risk Management, will present a session at the 46th DIA Annual Meeting (June 13-17, 2010 in Washington, DC.) Dr. Fermont will deliver a presentation on ‘A New Approach to Aggrega... Read more


ILSI BioMed in Tel-Aviv - June 14-16, 2010

Meet Israel’s biomedical innovation and healthcare at the ILSI-Biomed! ADDS will participate along with its network of expertise, Convergence. Dr. Irčne FERMONT, VP Pharmacovigilance & Risk Management, will give a presentation on ‘EMA Safety Requirements: From Clinical trials to Marketing Au... Read more


MakroCare (India) and ADDS sign exclusive partnership for Safety services

HYDERABAD - November 2009 Advanced Drug Development Services (ADDS) is a European CRO into advanced process of drugs and medical devices development. MakroCare is one of the fastest growing global CROs, situated in India and a leader in providing clinical and medical services at the internationa... Read more


CTrials Event

ADDS is sponsoring the CTrials Event in Ramat Gan, Israel, on October 28th. We will be glad to meet you there. For any further information please visit: ctrials.org.il or contact directly: aandre@adds.com January 28, 2009 Doctor Irčne FERMONT joins Advanced Drug Development Services as Vice-Pre... Read more


Clinical Trials in Emerging Markets

ADDS will be present at The Clinical Trials in Emerging Markets Conference - Clinical Trials in Emerging Markets/ Conference in The InterContinental Hotel, Vienna (Austria); Tuesday 24 and Wednesday 25 February 2009, Read more


ILSI-Biomed 2010

ADDS will be present at the next ILSI-Biomed 2010 Conference to be held June 14-16, 2010 in Tel-Aviv. Adam Svobodnik will present on June 15th the advantage to collaborate through the Convergence Network. Read more


January 2008 - ADDS expands its activities in Africa

ADDS North Africa has been created to develop and better coordinate Clinical Research activities in Africa, mainly in Algeria, Morocco and Tunisia Read more


September 2007- ADDS expands its activities in Israel

ADDS has opened a new office in Raanana (Israel) to develop its activities with the biotechnology centres in Israel and in the world. Dr Michel Levy becomes the C.E.O of the Israeli organization and will work closely with local organisations, biotechs and Israeli Universities. Read more


ADDS expands its activities in Eastern Europe

ADDS has signed agreements for the foundation of ADDS & DSC International s.r.o, a joint-venture between ADDS and DSC, Czech CRO close to the Masaryk University of Brno and specialized in data management and in biostatistics. This operation allows ADDS to expands its activities and its netwo... Read more


Eurosage

ADDS, coordinator of the European Eurosage project Read more


Earlier news

January 2nd, 2006: ADDS and Pharmnet, a Czech CRO with extensive experience in Clinical Research, have decided to join their force for activities in Eastern Europe. From January 2006, ADDS will be responsible for all Data Management, Biostatistics and Medical Writing activities for both companie... Read more